Carvone

150.22

150.22

202-759-5

93738|6275

DTXSID8047426

Pale-yellowish or colorless liquid

17.1

2.4

0.9600 g/cm³ @ Temp: 26 °C

100 °C

231 °C

88.9±0.0 °C

1.481

soluble in alcohol, ether, chloroform, propylene glycol, mineral oils; insoluble in glycerol

0.115 mm Hg at 25 deg C (est)

Henry's Law constant = 7.73X10-5 atm-cu m/mol at 25 °C (est)

Taste: minty /L-Carvone/|Liquid. BP: 230-231 °C at 763 mm Hg; density: 0.9652 at 15 °C/15 °C; index of refraction: 1.4988 at 20 °C/D; specific optical rotation: -62.46 deg at 20 °C/D /L-Carvone/|log Kow = 2.71 /L-Carvone/|Liquid. BP: 230 °C at 755 mm Hg; density: 0.965 at 20 °C/4 °C; index of refraction: 1.4989 at 20 °C/D; specific optical rotation: +61.2 deg at 20 °C/D /d-Carvone/|Odor reminiscent of caraway /D-Carvone/|Rye bread odor and taste /D-Carvone/|Density: 0.9645 at 15 °C/15 °C. Miscible with alcohol; index of refraction: 1.5003 at 20 °C/D /DL-Carvone/|Slightly soluble in hot water; soluble in ether, chloroform; max absorption (alcohol): 235 nm (log e = 3.93), 318 nm (log e= 1.62) /DL-, L- and D-Carvone/|Hydroxyl radical reaction rate constant = 1.41X10-10 cu cm/molc-sec at 25 °C (est)|Ozone rate constant = 8.59X10-17 cu cm/molecule-sec at 25 °C (est)

P261, P264, P270, P272, P280, P301+P312, P302+P352, P321, P330, P333+P313, P363, P501

H302

SRP: Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in air, soil or water; effects on animal, aquatic and plant life; and conformance with environmental and public health regulations. If it is possible or reasonable use an alternative chemical product with less inherent propensity for occupational harm/injury/toxicity or environmental contamination.

Synthetic flavoring substances and adjuvants /for human consumption/ that are generally recognized as safe for their intended use, within the meaning of section 409 of the Act. d- or l-Carvone is included on this list.|Synthetic flavoring substances and adjuvants /for animal drugs, feeds, and related products/ that are generally recognized as safe for their intended use, within the meaning of section 409 of the Act. d- or l-Carvone is included on this list.

DHHS/NTP; Toxicology & Carcinogenesis Studies of d-Carvone in B6C3F1 Mice (Gavage Studies) Technical Report Series No. 381 (1990) NIH Publication No. 90-2836

|Warning|H302 (53.77%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P272, P280, P301+P312, P302+P352, P321, P330, P333+P313, P363, and P501|Aggregated GHS information provided by 505 companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.|H317: May cause an allergic skin reaction [Warning Sensitization, Skin]|P261, P272, P280, P302+P352, P321, P333+P313, P363, and P501

Carvone was identified as a volatile compound from garden plant waste(1,2).

IDENTIFICATION AND USE: Carvone is a pale-yellowish or colorless liquid. The following uses have been identified for carvone: pesticide, feed additive, veterinary medicine use, flavoring substance and natural food occurrence, personal care products: D- and L-carvone are used in a variety of non-food consumer products, including cosmetics and personal care products. Some of these, such as toothpaste and mouthwash may result in oral intake of carvone. It is also used as natural insect repellent. HUMAN EXPOSURE AND TOXICITY: The sensitizing potential of l-carvone has been considered low, but it has occasionally caused contact allergy in users of spearmint toothpaste and chewing gum. L-Carvone inhibited proliferation of MCF 7 and MDA MB 231 cells and inhibited the migration of breast cancer cell lines. L-carvone induced apoptosis as observed by nuclei fragmentation and the presence of apoptotic bodies in DAPI, AnnexinV/propidium iodide, and TUNEL assays. l-carvone exposure arrested MCF 7 cells in S phase of the cell cycle. DNA damage caused by L-carvone was apparent from the increased tail moment in comet assay, which could be induced by an increase in ROS that was measured using a fluorescence probe. ANIMAL STUDIES: Clinical signs after acute exposure in mice and rats were different depending on the route of exposure. After acute oral administration, these included hunched posture and lethargy and occasional body tremor with no abnormalities at necropsy. After acute dermal exposure no systemic or skin effects were observed whereas after inhalation of carvone, respiratory effects were noted as well as alopecia and impairment of body weight gain. Carvone caused transient depression of central nervous system activity in mice. In developmental study rats were given 0, 3, 10 or 30 mg/kg/day of D-carvone (95%) for 10 weeks prior to mating until termination. There were no differences between treated and control animals in any of the indices of reproductive performance or in the results of the sperm morphology and motility measurements. Males of the F0 generation given 30 mg/kg bw/day had increased relative kidney weights. Histopathology of the male kidneys showed changes typical of alpha2u-globulin nephropathy at all doses. No other histopathological changes were reported and no similar changes were observed in females. Males of the F1 generation given 30 and 90 mg/kg bw/day had increased mean relative liver and kidney weights. Histopathology of the male kidneys showed changes typical of alpha2u-globulin nephropathy at all doses. No differences were seen in females and no other histopathological changes were reported. Carvone showed equivocal results for mutagenicity in a sister chromatid exchange study and a chromosomal aberration study with Chinese hamster ovary cells. Results from an in vivo UDS assay in liver and an in vivo micronucleus test were negative while those of an in vitro test for chromosome aberrations were not clear-cut. It was concluded that carvone should not be considered genotoxic. Groups of 50 male and 50 female mice were administered 0, 375, or 750 mg/kg D-carvone in corn oil by gavage, 5 days/wk for 103 weeks. Under the conditions of these two yr gavage studies, there was no evidence for the carcinogenic activity of D-carvone for male or female mice.

The objective was to investigate the difference in penetration enhancing effect of R-carvone, S-carvone and RS-carvone on the in vitro transdermal drug permeation. In vitro permeation studies were carried out across neonatal rat epidermis from 2% w/v HPMC (hydroxypropyl methylcellulose) gel containing 4% w/v of nicorandil (a model drug) and a selected concentration (12% w/v) of either R-carvone, S-carvone, or RS-carvone against a control. The stratum corneum (SC) of rats was treated with vehicle (70 %v/v ethanol-water) or ethanolic solutions of 12% w/v R-carvone, S-carvone or RS-carvone. The enhancement ratio (ER) of R-carvone, S-carvone, and RS-carvone when compared to control was about 37.1, 31.2, and 29.9, respectively, indicating enantioselective penetration enhancing effect of carvone enantiomers. Furthermore, there was a significant decrease in the lag time required to produce a steady-state flux of nicorandil with S-carvone when compared to R-carvone and RS-carvone. DSC and FT-IR studies indicate that the investigated enantiomers of carvone exhibit a difference in their ability to affect the cellular organization of SC lipids and proteins thereby showing enantioselective transdermal drug permeation. It was concluded that R-carvone exhibited a higher penetration enhancing activity on transdermal permeation of nicorandil when compared to its S-isomer or racemic mixture.|Naturally occurring compounds belonging to the two chemical groups were studies for their capacities to inhibit N-nitrosodiethylamine-induced carcinogenesis in female A/J mice. One group consists of organosulfur compounds found in Allium species, including garlic, onions, leeks, and shallots, and the other, two monoterpenes, i.e., D-limonene and D-carvone. In these experiments D-limonene and D-carvone were tested and reduced forestomach tumor formation by slightly over 60% and pulmonary adenoma formation by about 35%. The results of these studies provide evidence of an increasing diversity of naturally occurring compounds having the capacity to inhibit nitrosamine carcinogenesis.|Carvone is a monoterpene that is present in spearmint (Mentha spicata) and caraway (Carum carvi) essential oils and has been shown to have anticonvulsant effects, likely through the blockade of voltage-gated sodium channels, and anxiolytic-like effects. Considering that some anticonvulsants that blocked voltage-gated sodium channels (e.g., sodium valproate and carbamazepine) exert clinical antimanic effects, the aim of the present study was to evaluate (R)-(-)-carvone and (S)-(+)-carvone in animal models of mania (i.e., hyperlocomotion induced by methylphenidate and sleep deprivation). Mice that were treated with methylphenidate (5 mg/kg) or sleep-deprived for 24 hr using a multiple-platform protocol exhibited an increase in locomotor activity in an automated activity box. This effect was blocked by pretreatment with acute (R)-(-)-carvone (50-100 mg/kg), (S)-(+)-carvone (50-100 mg/kg), and lithium (100 mg/kg, positive control). These doses did not alter spontaneous locomotor activity in the methylphenidate-induced experiments while (S)-(+)-carvone decreased spontaneous locomotor activity in sleep deprivation experiment, indicating a sedative effect. Chronic 21-day treatment with (R)-(-)-carvone (100 mg/kg), (S)-(+)-carvone (100 mg/kg), and lithium also prevented methylphenidate-induced hyperactivity. The present results suggest that carvone may have an antimanic-like effect.

LD50 Rat oral 1,640 mg/kg bw /D-Carvone/|LD50 Rat oral >2000 mg/kg bw|LD50 Guinea pig oral 766 mg/kg bw /D-Carvone/|LD50 Rat (female) oral 2263 mg/kg bw|For more Non-Human Toxicity Values (Complete) data for CARVONE (11 total), please visit the HSDB record page.

/OTHER TERRESTRIAL SPECIES/ The efficacy of 30 aromatic compounds and their mutual binary combinations was assessed for acute toxicity agains the larvae Culex quinquefasciatus. Based on comparison of the lethal doses, thymol and p-cymene were selected as the most effective (LD50 = 18 and 21 mg/L, respectively, and LD90 = 25 and 30 mg/L, respectively). Although the LD50 for terpinolene and trans-anethole was also estimated at 21 mg/L), their LD90 was significantly higher compared to the substances above (245 and 34 mg/L, respectively). In total, 435 binary combinations were tested, of which 249 combinations showed a significant synergistic effect, while 74 combinations showed a significant antagonistic effect on mortality. Only nine substances were identified as being able to create a synergistic effect with more than 20 substances: limonene, trans-anethole, 4-allylanisole, carvacrol, isoeugenol, menthone, carvone, borneol, and camphor. The highest synergistic effect on larval mortality was achieved for the combinations: eugenol and isoeugenol, carvone and carvacrol, carvone and 4-allylanisole, carvone and a-terpineol, carvone and menthone, limonene and trans-anethole, limonene and menthone, a-pinene and menthone, beta-citronellol and menthone, carvacrol and 4-allylanisole, carvacrol and terpineol, a-terpinene and trans-anethole, camphor and menthone, camphene and menthone, and 4-allylanisole and menthone. Significant differences between achieved mortality and the mutual mixing ratio were found for the five selected binary mixtures that had shown the most significant synergistic effect in the previous tests. The mixture of limonene and trans-anethole showed the highest mortality, with the mixing ratio 1:1; the mixture of eugenol and isoeugenol caused 90.2% mortality, with the mixing ratio 1:3. One hundred percent mortality was achieved if carvacrol was contained in a mixture with carvone in a ratio >2. After a comparison of all our results, based on our experiments, we can choose two pairs that caused mortality higher than 90% in concentrations lower than 20 mg/L: limonene and trans-anethole (with the mixing ratio 1:1), and carvone and carvacrol (with the mixing ratio 1:2-3). The information gained can thus be used in the development of new botanical insecticides based on essential oils (EOs) and particularly in the creation of formulations.

Groups of 50 male and 50 female B6C3F1 mice were administered 0, 375, or 750 mg/kg D-carvone in corn oil by gavage, 5 days/wk for 103 wk. ... Under the conditions of these two yr gavage studies, there was no evidence for the carcinogenic activity of D-carvone for male or female B6C3F1 mice. ... /D-Carvone/

Carvone is found in gingergrass oil and is the main constituent of spearmint oil(1,2). The optically active form D-carvone is found in caraway seed and dill seed oil and it has been isolated from mandarin peel oil (Citrus reticulata blanco, Rutaceae)(1). Optically active form L-carvone is found in spearmint and kuromoji oils(1). The most significant natural sources of carvone are spearmint, dill, and caraway. The term spearmint is applied to various Mentha species including M. cardiaca, M. gracilis, M. spicata, and M. viridis and these usually contain 55-75% of the (R)-(-)-enantiomer. The (S)-(+)-enantiomer is found in dill (Anethum graveolens) at levels of 30-65% and at 50-75% in caraway (Carum carvi)(3).|Carvone occurs in several plants and plant tissues(1). Optically active and inactive forms of carvone have been reported among constituents of about 70 essential oils(2). D-Carvone is present in Carvi sp., Anethum graveolens, Anethum sowa, Lippia carviodora, Mentha arvensis, etc. L-Carvone is present in Mentha viridis var crispa, Mentha longifolia from South Africa, Eucalyptus globulus, and several mint species. Racemic or DL-carvone is present in ginger grass, Litsea guatemaleusis, lavender, and Artemisia ferganensis(2).

Carvone's production and use as a flavoring agent, in perfumery and soaps, and as a carminative(1) may result in its release to the environment through various waste streams(SRC). The optically acrive form, L-carvone's production may result in its release to the environment through various waste streams; its use as a pesticide active ingredient(2) will result in its direct release to the environment(SRC).

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 140(SRC), determined from a structure estimation method(2), indicates that carvone is expected to have high mobility in soil(SRC). Volatilization of carvone from moist soil surfaces may be an important fate process(SRC) given an estimated Henry's Law constant of 7.73X10-5 atm-cu m/mole(SRC), using a fragment constant estimation method(3). Carvone has an estimated vapor pressure of 0.115 mm Hg(SRC), determined from a fragment constant method(2), and exists as a liquid under environmental conditions; therefore, carvone may volatilize from dry soil(SRC). Using the optically active form L-carvone in the Manometric Respirometry test, 90% biodegradation of L-carvone was reached in 4 weeks(4) suggesting that biodegradation of carvone may be an important environmental fate process in soil(SRC).[(1) Swann RL et al; Res Rev 85: 17-28 (1983) (2) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of June 14, 2016: http://www2.epa.gov/tsca-screening-tools (3) Meylan WM, Howard PH; Environ Toxicol Chem 10: 1283-93 (1991) (4) ECHA; Registered Substances. L-p-mentha-1|AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 140(SRC), determined from a structure estimation method(2), indicates that carvone is not expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is expected(3) based upon an estimated Henry's Law constant of 7.73X10-5 atm-cu m/mole(SRC), developed using a fragment constant estimation method(4). Using this Henry's Law constant and an estimation method(3), volatilization half-lives for a model river and model lake are 11 hours and 9 days, respectively(SRC). According to a classification scheme(5), an estimated BCF of 30(SRC), from an estimated log Kow of 3.07(2) and a regression-derived equation(2), suggests the potential for bioconcentration in aquatic organisms is moderate(SRC). Using the optically active form L-carvone in the Manometric Respirometry test, 90% biodegradation of L-carvone was reached in 4 weeks(6) suggesting that biodegradation of carvone may be an important environmental fate process in water(SRC).[(1) Swann RL et al; Res Rev 85: 17-28 (1983) (2) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of June 14, 2016: http://www2.epa.gov/tsca-screening-tools (3) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 15-1 to 15-29 (1990) (4) Meylan WM, Howard PH; Environ Toxicol Chem 10: 1283-93 (1991) (5) Franke C et al; Chemosphere 29: 1501-14 (1994) (6) ECHA; Registered Substances. L-p-mentha-1|ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), carvone, which has an estimated vapor pressure of 0.115 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), is expected to exist solely as a vapor in the ambient atmosphere. Vapor-phase carvone is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 3 hours(SRC), calculated from its rate constant of 1.41X10-10 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Carvone contains chromophores that absorb at wavelengths >290 nm(4) and, therefore, may be susceptible to direct photolysis by sunlight(SRC).

The rate constant for the vapor-phase reaction of carvone with photochemically-produced hydroxyl radicals has been estimated as 1.41X10-10 cu cm/molecule-sec at 25 °C(SRC) using a structure estimation method(1). This corresponds to an atmospheric half-life of about 3 hours at an atmospheric concentration of 5X10+5 hydroxyl radicals per cu cm(1). The rate constant for the vapor-phase reaction of carvone with ozone has been estimated as 8.59X10-17 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(1). This corresponds to an atmospheric half-life of about 3 hours at an atmospheric concentration of 7X10+11 ozone molecules per cu cm(2). Carvone is not expected to undergo hydrolysis in the environment due to the lack of functional groups that hydrolyze under environmental conditions(3). Carvone contains chromophores that absorb at wavelengths >290 nm(3) and, therefore, may be susceptible to direct photolysis by sunlight(SRC).

An estimated BCF of 30 was calculated in fish for carvone(SRC), using an estimated log Kow of 3.07(1) and a regression-derived equation(1). According to a classification scheme(2), this BCF suggests the potential for bioconcentration in aquatic organisms is moderate(SRC).

Using a structure estimation method based on molecular connectivity indices(1), the Koc of carvone can be estimated to be 140(SRC). According to a classification scheme(2), this estimated Koc value suggests that carvone is expected to have high mobility in soil.

The Henry's Law constant for carvone is estimated as 7.73X10-5 atm-cu m/mole(SRC) using a fragment constant estimation method(1). This Henry's Law constant indicates that carvone is expected to volatilize from water surfaces(2). Based on this Henry's Law constant, the volatilization half-life from a model river (1 m deep, flowing 1 m/sec, wind velocity of 3 m/sec)(2) is estimated as 11 hours(SRC). The volatilization half-life from a model lake (1 m deep, flowing 0.05 m/sec, wind velocity of 0.5 m/sec)(2) is estimated as 9 days(SRC). Carvone's Henry's Law constant indicates that volatilization from moist soil surfaces may occur(SRC). Carvone has an estimated vapor pressure of 0.115 mm Hg(SRC), determined from a fragment constant method(3) and exists as a liquid under environmental conditions; therefore, carvone may volatilize from dry soil(SRC).

Carvone has been detected as a volatile component of roasted filberts(1) and in concentrated aqueous orange essences(2).

Occupational exposure to carvone may occur through inhalation and dermal contact with this compound at workplaces where carvone is produced or used. Limited monitoring and use data indicate that the general population may be exposed to carvone via ingestion of food and inhalation of certain spice aromas and dermal contact with consumer products containing carvone. (SRC)

Veterinary use: Carvi aetheroleum (containing D-carvone) is used in veterinary medicinal products to facilitate breathing in new-borne animals, and to treat flatulence and disturbances of the stomach and the gut in farmed animals.|...Carvi aetheroleum and carvi fructus are registered as herbal medicinal products by the European Medicines Agency. Uses as a laxative, in colic treatment, as a breath freshener, or to help digestion in young children have been reported. Other properties claimed for caraway seeds include antispasmodic, carminative, emmenagogue, expectorant, galactagogue, stimulant, stomachic, and tonic properties.

Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)

In humans, D-carvone pharmacokinetics was investigated in 15 male volunteers who, after a 10 hr fast, took 5 capsules of an immediate release formulation containing 20 mg caraway oil. Carvone concentrations in plasma were determined by GC/MS, with a limit of quantification of 0.5 ng/mL for carvone. Pharmacokinetic parameters were determined, i.e., area-under the plasma-concentration curve (AUC) of 28.9+/- 20.0 ng.mL/hr , plasma peak concentration (Cmax) of 14.8+/-10.4 ng/mL with a time to reach Cmax (Tmax) of 1.3 hours and a half life of 2.4 hours. Inter-individual differences determined as the coefficients of variation in AUC, Cmax, and t1/2 were 69%, 74%, and 50% respectively. /D-Carvone/

As part of a program aiming at the selection of yeast strains which might be of interest as sources of natural flavors and fragrances, the bioreduction of (4R)-(-)-carvone and (1R)-(-)-myrtenal by whole-cells of non-conventional yeasts (NCYs) belonging to the genera Candida, Cryptococcus, Debaryomyces, Hanseniaspora, Kazachstania, Kluyveromyces, Lindnera, Nakaseomyces, Vanderwaltozyma, and Wickerhamomyces was studied. Volatiles produced were sampled by means of headspace solid-phase microextraction (SPME) and the compounds were analyzed and identified by gas chromatography-mass spectroscopy (GC-MS). Yields (expressed as % of biotransformation) varied in dependence of the strain. The reduction of both (4R)-(-)-carvone and (1R)-(-)-myrtenal were catalyzed by some ene-reductases (ERs) and/or carbonyl reductases (CRs), which determined the formation of (1R,4R)-dihydrocarvone and (1R)-myrtenol respectively, as main flavoring products. The potential of NCYs as novel whole-cell biocatalysts for selective biotransformation of electron-poor alkenes for producing flavors and fragrances of industrial interest is discussed.|... Ketones (e.g., carvone and menthone) are reduced to secondary alcohols which are then excreted as glucuronides.|The cyclic monoterpene ketone (-)-carvone was metabolized by the plant pathogenic fungus Absidia glauca. After 4 days of incubation, the diol 10-hydroxy-(+)-neodihydrocarveol was formed. The absolute configuration and structure of the crystalline substance was identified by means of X-ray diffraction and by spectroscopic techniques (MS, IR, and NMR). The antimicrobial activity of the substrate and metabolite was assayed with human pathogenic microorganisms.|D-Carvone toxicokinetics in humans features rapid elimination with a half life of 2.4 hours, no data are available for L-carvone. No toxicokinetic data on carvone in animals are available. The evidence from in vivo, in vitro, and in silico assessments has shown that carvone metabolism is likely to be different in humans and rats - with further possible differences between metabolism in male and female rats. It is also evident that when compared with carvone itself, the metabolites are not likely to be different in terms of GI uptake or half-life in the body. Toxicokinetic data on other monoterpenes in the rat such as menthol suggest that metabolism involves conjugation to a glucuronide for which enterohepatic recirculation occurs in the rat but not in humans. Considering the molecular weight of glucuronidated carvone metabolites, they may undergo enterohepatic recirculation in rats but not in humans, making the rat more sensitive than humans for these compounds. /D-Carvone and L-Carvone/|In vivo metabolism of D- and L-carvone has been investigated in six human volunteers (three males, three females) after oral dosing (1 mg/kg bw), with collection of urine samples 24 hr before and after the ingestion of each enantiomer separately. Chemical structures of the metabolites were elucidated using mass spectral analysis in combination with metabolite syntheses and NMR analysis. For this, the urinary samples were treated with sulphatase and glucuronidase, assuming conjugation of phase I metabolites. However, no quantitative data on excretion of conjugated forms of the metabolites were reported. The study identified three side-chain oxidation products as the main primary unconjugated metabolites of D- and L-carvone: dihydrocarvonic acid, carvonic acid, and uroterpenolone, with 10-hydroxycarvone as the proposed intermediate metabolic step. However, unlike other species, the presence of 10-hydroxycarvone was not detected in humans and /it was/ suggested this was due to more efficient oxidation of 10-hydroxycarvone leading to carvonic acid. According to /the study/, there were no differences in the metabolism of D- and L-carvone. However, the results presented only refer to "after carvone ingestion", although apparently both carvone enantiomers were ingested by the volunteers in independent trials. According to the author, all metabolites were identical after the application of either D- or L-carvone. However, the configurations of metabolites were not identified and the chromatographic analyses were only performed on a nonchiral stationary phase. This experimental set-up does not allow differentiation of the stereospecific metabolism of D- and L-carvone. /D-Carvone and L-Carvone/

D-Carvone toxicokinetics in humans features rapid elimination with a half life of 2.4 hours, no data are available for L-carvone. /D-Carvone/

/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Poisons A and B/|/SRP:/ Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 mL/kg up to 200 mL of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poisons A and B/|/SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive-pressure ventilation techniques with a bag-valve-mask device may be beneficial. Consider drug therapy for pulmonary edema ... . Consider administering a beta agonist such as albuterol for severe bronchospasm ... . Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start IV administration of D5W TKO. Use 0.9% saline (NS) or lactated Ringer's (LR) if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam (Valium) or lorazepam (Ativan) ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Poisons A and B/|Emergency and supportive measures. 1. Maintain an open airway and assist ventilation if necessary. 2. Treat seizures and come if they occur. /Camphor and other essential oils/|For more Antidote and Emergency Treatment (Complete) data for CARVONE (6 total), please visit the HSDB record page.

/HUMAN EXPOSURE STUDIES/ The terpene L-carvone is one of the main constituents of spearmint oil. The sensitizing potential of L-carvone has been considered low, but it has occasionally caused contact allergy in users of spearmint toothpaste and chewing gum. L-Carvone is also an oxidation product of D-limonene that occurs in solvents used increasingly in industry. We included L-carvone 5% pet. in the standard patch test series. In the 1st year, 541 patients were tested and 15 (2.77%) had positive, and 12 doubtful positive (?+) reactions to L-carvone. The strongest reactions were observed in 9 patients with concomitant Compositae sensitivity. The key clinical features and other contact allergies of the patients are presented. When re-testing with L-carvone in the same or lower concentrations, only 2 out of 8 patients had positive reactions. Possible reasons for this discrepancy are discussed in terms of cross-reactions, concomitant sensitization, excited skin syndrome, irritancy and facilitated immunological response. /L-Carvone/|/HUMAN EXPOSURE STUDIES/ A maximization test was carried out on 25 volunteers. The material was tested at a concentration of 1% in petrolatum and produced no sensitization reactions. /L-Carvone/|/HUMAN EXPOSURE STUDIES/ L-Carvone tested at concentration of 1% in petrolatum produced no irritation after a 48-hr closed-patch test in 25 human subjects. /L-Carvone/|/CASE REPORTS/ Food or flavoring intolerance has been demonstrated in 14 out of 80 patients with oro-facial granulomatosis. Provoking molecules include cinnamaldehyde, carvone, and piperitone, although a wide range of food or flavorings may be implicated. The nature of the reaction is not understood but does not seem to involve an IgE mediated response. At present the only reliable way of detecting specific provoking factors is by the use of an elimination diet.|For more Human Toxicity Excerpts (Complete) data for CARVONE (7 total), please visit the HSDB record page.

(RS)-5-isopropenyl-2-methylcyclohex-2-en-1-one

Grades: FCC /Food Chemicals Codex/ (both d- and l-forms); technical|The proportion of carvone in herb oil has been reported to vary from 6 to 44%, depending on the geographical origin ... while the amount of carvone in the oil of dill seeds is more constant, 40-55%.

2-Cyclohexen-1-one, 2-methyl-5-(1-methylethenyl)-: ACTIVE|The most significant natural sources of carvone are spearmint, dill, and caraway. The term spearmint is applied to various Mentha species including M. cardiaca, M. gracilis, M. spicata, and M. viridis and these usually contain 55-75% of the (R)-(-)-enantiomer. The (S)-(+)-enantiomer is found in dill (Anethum graveolens) at levels of 30-65% and at 50-75% in caraway (Carum carvi).|A ketone derived from the terpene dipentene. It is optically active, and occurring naturally in both d- and l-forms.

Gas chromatography, mass spectroscopy, IR, and NMR spectra.|Paramagnetic resonance assay of carvone in caraway and dill oils.|Colorimetric determination of carvone in volatile oils.|The enantiomers D-carvone and L-carvone cannot be separated with standard chromatographic techniques. Therefore, no distinction can be made between these stereoisomers, unless specific approaches, such as the use of chiral stationary phases in capillary gas chromatography or the use of chiral shift reagents in NMR spectroscopy, are employed.

Food additives -> Flavoring Agents|Agrochemicals -> Plant Growth Regulators|Pharmaceuticals|Cosmetics -> Masking

Flavoring Agents